Schneidawind Dominik
Innere Medizin II, Medizinische Klinik, Universitätsklinikum Tübingen, Otfried-Müller-Str. 10, 72076, Tübingen, Deutschland.
Pathologe. 2020 Dec;41(Suppl 2):134-137. doi: 10.1007/s00292-020-00829-1.
Invariant natural killer T cells (iNKT cells) are a small subset of T lymphocytes that are equipped with various immunoregulatory cytokines and cytotoxic effector molecules. Immune responses can be modulated efficiently by their interaction with other cells of the innate and adaptive immune system. Also, iNKT cells can promote apoptosis of malignant cells. Therefore, iNKT cells play a particular role in infectious diseases, malignant diseases, autoimmunity and alloimmunity. After allogeneic hematopoietic cell transplantation, iNKT cells induce immune tolerance and promote graft-versus-tumor effects. Recent advances in automated cell processing under good manufacturing practice (GMP) conditions and genetic modifications of effector cells pave the way for clinical translation of iNKT cell therapy.
不变自然杀伤T细胞(iNKT细胞)是T淋巴细胞的一个小亚群,配备有多种免疫调节细胞因子和细胞毒性效应分子。通过与先天性和适应性免疫系统的其他细胞相互作用,免疫反应可得到有效调节。此外,iNKT细胞可促进恶性细胞的凋亡。因此,iNKT细胞在传染病、恶性疾病、自身免疫和同种免疫中发挥着特殊作用。异基因造血细胞移植后,iNKT细胞可诱导免疫耐受并促进移植物抗肿瘤效应。在良好生产规范(GMP)条件下进行的自动化细胞处理以及效应细胞的基因改造方面的最新进展为iNKT细胞疗法的临床转化铺平了道路。